Inhibrx Biosciences shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Inhibrx Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx Biosciences held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibrx Biosciences by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $163k | 4.8k | 33.68 |
| 2025-03-31 | $90k | 6.4k | 13.99 |
| 2024-12-31 | $117k | 7.6k | 15.40 |
| 2024-09-30 | $80k | 5.1k | 15.66 |
| 2024-06-30 | $627k | 44k | 14.17 |